Modulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation.

Current atherosclerosis reports

Volumn 15, Issue 5, 2013, Pages

  Hadoke, Patrick W F ^a   Kipari, Tiina ^b   Seckl, Jonathan R ^b   Chapman, Karen E ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; GLUCOCORTICOID;

ATHEROSCLEROSIS; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; IMMUNOLOGY; METABOLISM; NEOINTIMA; PHYSIOLOGY; REVIEW; VASCULITIS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ATHEROSCLEROSIS; GLUCOCORTICOIDS; HUMANS; NEOINTIMA; VASCULITIS;

EID: 84883688466     PISSN: None     EISSN: 15346242     Source Type: None    
DOI: 10.1007/s11883-013-0320-1     Document Type: Review

References (0)